NCT03003962 2026-03-11Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)AstraZenecaPhase 3 Active not recruiting669 enrolled 54 charts
NCT03307785 2025-11-25Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042Tesaro, Inc.Phase 1 Completed60 enrolled 91 charts
NCT03519971 2025-10-28Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung CancerAstraZenecaPhase 3 Active not recruiting328 enrolled 23 charts